Semine, Josephine .
HRN: 28-22-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2025
AMPICILLIN 1GM (VIAL)
12/22/2025
12/28/2025
IV
2g
Q6HRS
THINLY MsaF
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes